SpectraMax M3 Multi-mode microplate reader
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), under the Department of Health and Human Services, is soliciting proposals for a SpectraMax M3 Multi-mode Microplate Reader or equivalent system. This unrestricted combined synopsis/solicitation (RFQ 75N98026Q00657) aims to procure advanced laboratory equipment for biomedical research at NIH facilities in Bethesda, MD. Proposals are due June 29, 2026, at 1:00 PM EDT.
Scope of Work
The requirement is for one (1) SpectraMax M3 Microplate Reader or equivalent, including the latest SoftMax Pro software license. The scope covers installation, operational verification, user training, and options for warranty and service agreements. The system will support high-quality, reproducible assay data acquisition and analysis.
Technical Requirements
The system must feature absorbance (200–1000 nm), fluorescence intensity, and luminescence detection capabilities. Key technical specifications include monochromator-based wavelength selection, temperature control, plate shaking, and both kinetic and endpoint read functionality. The accompanying software should offer advanced analysis and 21 CFR Part 11 capability where applicable.
Contract & Timeline
- Type: Firm Fixed Price (Combined Synopsis/Solicitation, RFQ)
- Set-Aside: Unrestricted
- NAICS: 334516 (Small Business Size Standard: 1,000 employees)
- Acquisition Procedures: FAR Part 12 and FAR Part 13
- Response Due: June 29, 2026, 1:00 PM EDT
- Place of Performance: NIH facilities – Thoracic and GI Malignancies Branch, CCR, NCI, Bethesda, MD
- Delivery/Installation: Within 4–8 weeks after award
- Contact: Towanda Daniels, Purchasing Agent (danielt@mail.nih.gov)
Evaluation Criteria
Offers will be evaluated based on Technical, Past Performance, and Cost. Technical and Past Performance factors, when combined, are significantly more important than cost or price. The Government intends to award to the responsible offeror whose proposal is most advantageous.
Additional Notes
This is a combined synopsis/solicitation; a separate written solicitation will not be issued. Offerors must comply with FAR Clause 52.212-1 (Instructions to Offerors), including addenda for additional attachments like the Statement of Work. FAR Clause 52.212-3 (Representations and Certifications) must be completed, with paragraph (b) applicable if registered in SAM.gov. FAR Clauses 52.212-4 and 52.212-5, along with their addenda, also apply.